Global Veterinary Oncology Market Size study, by Therapy (Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Others) by Animal type (Canine, Feline) by Cancer Type (Lymphoma, Mast Cell Cancer, Mammary and Squamous Cell Cancer, Others) and Regional Forecasts 2022-2028
Global Veterinary Oncology Market is valued approximately USD 207.5 million in 2021 and is anticipated to grow with a healthy growth rate of more than 12.1% over the forecast period 2022-2028. Veterinary oncology is the treatment of cancer-stricken pets in order to improve their quality of life. One of the most common causes of mortality in pets is cancer. Skin cancer and bone cancer are more common in dogs and cats. Due to constant exposure of animal skin to UV rays, skin tumors are the most prevalent and often diagnosed cancer in domestic animals. Veterinarians utilize the HHHHHMM scale to assess the quality of life of pet owners before making treatment decisions for diseases like cancer. The rising prevalence of cancer in the pet population, together with the increased use of veterinary cancer therapy as a treatment strategy, is driving market expansion. Another element driving market expansion is the global use of canine cancer registry to quantify cancer incidences. According to Frontiers in Veterinary Science in February 2019, The Swiss Canine Cancer Registry (SCCR) was used as a data source and was developed for future comparison research of canine and human cancers.. This database is also useful in reducing the occurrence of malignant tumours in the human population, resulting in market expansion. Researchers working on veterinary oncology studies are helping to propel the veterinary oncology market forward. For example, the University of Illinois conducted a study in August 2017 that involved more precise identification of metastasis (cancer spread throughout the body) in dogs with head and neck cancers. Furthermore, market participants are concentrating on new product development and strategic partnerships. For example, in 2018, AdvaVet, an Oasmia Pharmaceutical AB company, launched XR17 technology, which is based on nanoparticle formulation and makes a single Active Pharmaceutical Ingredient (API) or numerous APIs water soluble. It is a combined therapy that is also used to treat a variety of cancer conditions in pets. Major drivers driving the market are increased expenditure on animal healthcare in developed economies due to rising willingness to spend on pet healthcare by owners and government initiatives for veterinary cancer treatment. In addition, the American Veterinary Medical Association (AVMA) predicted in October 2019 that one out of every four dogs may have neoplasia at some point in their lifetimes. However, the high cost of veterinary cancer therapy, as well as side effects of oncology medications including as hair loss, decreased appetite, and vomiting, will stifle market expansion between 2022 and 2028.
The key regions considered for the global Veterinary Oncology Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the veterinary oncology market. Over the forecast period, the segment is expected to dominate the market. The growing focus on pet health, the presence of a large number of pet medicine manufacturing companies, and the rapid acceptance of novel pet care medications are all contributing to market growth. Furthermore, the government's increased support for pet oncology treatment in this region, as well as the existence of market behemoths in the oncology market, are boosting the market. The market in Asia Pacific is likely to develop over the forecast period as veterinarians become more aware of various treatment procedures for pets, veterinary healthcare infrastructure improves, and animal healthcare expenditure rises.
Major market player included in this report are:
PetCure Oncology
Zoetis
Karyopharm Therapeutics, Inc.
Varian Medical Systems
Accuray Incorporated
Boehringer Ingelheim GmbH
Elanco
One Health
Regeneus Ltd.
Morphogenesis, Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal type:
Canine
Feline
By Cancer Type:
Lymphoma
Mast Cell Cancer
Mammary and Squamous Cell Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Veterinary Oncology Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The key regions considered for the global Veterinary Oncology Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the veterinary oncology market. Over the forecast period, the segment is expected to dominate the market. The growing focus on pet health, the presence of a large number of pet medicine manufacturing companies, and the rapid acceptance of novel pet care medications are all contributing to market growth. Furthermore, the government's increased support for pet oncology treatment in this region, as well as the existence of market behemoths in the oncology market, are boosting the market. The market in Asia Pacific is likely to develop over the forecast period as veterinarians become more aware of various treatment procedures for pets, veterinary healthcare infrastructure improves, and animal healthcare expenditure rises.
Major market player included in this report are:
PetCure Oncology
Zoetis
Karyopharm Therapeutics, Inc.
Varian Medical Systems
Accuray Incorporated
Boehringer Ingelheim GmbH
Elanco
One Health
Regeneus Ltd.
Morphogenesis, Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal type:
Canine
Feline
By Cancer Type:
Lymphoma
Mast Cell Cancer
Mammary and Squamous Cell Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Veterinary Oncology Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Veterinary Oncology Market, by Region, 2020-2028 (USD Million)
1.2.2. Veterinary Oncology Market, by Therapy, 2020-2028 (USD Million)
1.2.3. Veterinary Oncology Market, by Animal Type, 2020-2028 (USD Million)
1.2.4. Veterinary Oncology Market, by Cancer Type, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL VETERINARY ONCOLOGY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL VETERINARY ONCOLOGY MARKET DYNAMICS
3.1. Veterinary Oncology Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing pervasiveness of cancer in the pet population
3.1.1.2. Growing expenditure on animal healthcare
3.1.2. Market Challenges
3.1.2.1. High cost of veterinary cancer therapy
3.1.2.2. Side effects of oncology medications including as hair loss, decreased appetite, and vomiting
3.1.3. Market Opportunities
3.1.3.1. Increasing number of veterinary clinical studies for evaluating safety and efficacy of different oncologic treatments in pets.
3.1.3.2. Supportive government initiatives pertinent to veterinary cancer treatment
CHAPTER 4. GLOBAL VETERINARY ONCOLOGY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL VETERINARY ONCOLOGY MARKET, BY THERAPY
6.1. Market Snapshot
6.2. Global Veterinary Oncology Market by Therapy, Performance - Potential Analysis
6.3. Global Veterinary Oncology Market Estimates & Forecasts by Therapy 2018-2028 (USD Million)
6.4. Veterinary Oncology Market, Sub Segment Analysis
6.4.1. Surgery
6.4.2. Radiotherapy
6.4.3. Chemotherapy
6.4.4. Immunotherapy
6.4.5. Others
CHAPTER 7. GLOBAL VETERINARY ONCOLOGY MARKET, BY ANIMAL TYPE
7.1. Market Snapshot
7.2. Global Veterinary Oncology Market by Animal Type, Performance - Potential Analysis
7.3. Global Veterinary Oncology Market Estimates & Forecasts by Animal Type 2018-2028 (USD Million)
7.4. Veterinary Oncology Market, Sub Segment Analysis
7.4.1. Canine
7.4.2. Feline
CHAPTER 8. GLOBAL VETERINARY ONCOLOGY MARKET, BY CANCER TYPE
8.1. Market Snapshot
8.2. Global Veterinary Oncology Market by Cancer Type, Performance - Potential Analysis
8.3. Global Veterinary Oncology Market Estimates & Forecasts by Cancer Type 2018-2028 (USD Million)
8.4. Veterinary Oncology Market, Sub Segment Analysis
8.4.1. Lymphoma
8.4.2. Mast Cell Cancer
8.4.3. Mammary and Squamous Cell Cancer
8.4.4. Others
CHAPTER 9. GLOBAL VETERINARY ONCOLOGY MARKET, REGIONAL ANALYSIS
9.1. Veterinary Oncology Market, Regional Market Snapshot
9.2. North America Veterinary Oncology Market
9.2.1. U.S. Veterinary Oncology Market
9.2.1.1. Therapy breakdown estimates & forecasts, 2018-2028
9.2.1.2. Animal Type breakdown estimates & forecasts, 2018-2028
9.2.1.3. Cancer Type breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Veterinary Oncology Market
9.3. Europe Veterinary Oncology Market Snapshot
9.3.1. U.K. Veterinary Oncology Market
9.3.2. Germany Veterinary Oncology Market
9.3.3. France Veterinary Oncology Market
9.3.4. Spain Veterinary Oncology Market
9.3.5. Italy Veterinary Oncology Market
9.3.6. Rest of Europe Veterinary Oncology Market
9.4. Asia-Pacific Veterinary Oncology Market Snapshot
9.4.1. China Veterinary Oncology Market
9.4.2. India Veterinary Oncology Market
9.4.3. Japan Veterinary Oncology Market
9.4.4. Australia Veterinary Oncology Market
9.4.5. South Korea Veterinary Oncology Market
9.4.6. Rest of Asia Pacific Veterinary Oncology Market
9.5. Latin America Veterinary Oncology Market Snapshot
9.5.1. Brazil Veterinary Oncology Market
9.5.2. Mexico Veterinary Oncology Market
9.6. Rest of The World Veterinary Oncology Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. PetCure Oncology
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Therapy Summary
10.2.1.5. Recent Developments
10.2.2. Zoetis
10.2.3. Karyopharm Therapeutics, Inc.
10.2.4. Varian Medical Systems
10.2.5. Accuray Incorporated
10.2.6. Boehringer Ingelheim GmbH
10.2.7. Elanco
10.2.8. One Health
10.2.9. Regeneus Ltd.
10.2.10. Morphogenesis, Inc
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Veterinary Oncology Market, by Region, 2020-2028 (USD Million)
1.2.2. Veterinary Oncology Market, by Therapy, 2020-2028 (USD Million)
1.2.3. Veterinary Oncology Market, by Animal Type, 2020-2028 (USD Million)
1.2.4. Veterinary Oncology Market, by Cancer Type, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL VETERINARY ONCOLOGY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL VETERINARY ONCOLOGY MARKET DYNAMICS
3.1. Veterinary Oncology Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing pervasiveness of cancer in the pet population
3.1.1.2. Growing expenditure on animal healthcare
3.1.2. Market Challenges
3.1.2.1. High cost of veterinary cancer therapy
3.1.2.2. Side effects of oncology medications including as hair loss, decreased appetite, and vomiting
3.1.3. Market Opportunities
3.1.3.1. Increasing number of veterinary clinical studies for evaluating safety and efficacy of different oncologic treatments in pets.
3.1.3.2. Supportive government initiatives pertinent to veterinary cancer treatment
CHAPTER 4. GLOBAL VETERINARY ONCOLOGY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL VETERINARY ONCOLOGY MARKET, BY THERAPY
6.1. Market Snapshot
6.2. Global Veterinary Oncology Market by Therapy, Performance - Potential Analysis
6.3. Global Veterinary Oncology Market Estimates & Forecasts by Therapy 2018-2028 (USD Million)
6.4. Veterinary Oncology Market, Sub Segment Analysis
6.4.1. Surgery
6.4.2. Radiotherapy
6.4.3. Chemotherapy
6.4.4. Immunotherapy
6.4.5. Others
CHAPTER 7. GLOBAL VETERINARY ONCOLOGY MARKET, BY ANIMAL TYPE
7.1. Market Snapshot
7.2. Global Veterinary Oncology Market by Animal Type, Performance - Potential Analysis
7.3. Global Veterinary Oncology Market Estimates & Forecasts by Animal Type 2018-2028 (USD Million)
7.4. Veterinary Oncology Market, Sub Segment Analysis
7.4.1. Canine
7.4.2. Feline
CHAPTER 8. GLOBAL VETERINARY ONCOLOGY MARKET, BY CANCER TYPE
8.1. Market Snapshot
8.2. Global Veterinary Oncology Market by Cancer Type, Performance - Potential Analysis
8.3. Global Veterinary Oncology Market Estimates & Forecasts by Cancer Type 2018-2028 (USD Million)
8.4. Veterinary Oncology Market, Sub Segment Analysis
8.4.1. Lymphoma
8.4.2. Mast Cell Cancer
8.4.3. Mammary and Squamous Cell Cancer
8.4.4. Others
CHAPTER 9. GLOBAL VETERINARY ONCOLOGY MARKET, REGIONAL ANALYSIS
9.1. Veterinary Oncology Market, Regional Market Snapshot
9.2. North America Veterinary Oncology Market
9.2.1. U.S. Veterinary Oncology Market
9.2.1.1. Therapy breakdown estimates & forecasts, 2018-2028
9.2.1.2. Animal Type breakdown estimates & forecasts, 2018-2028
9.2.1.3. Cancer Type breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Veterinary Oncology Market
9.3. Europe Veterinary Oncology Market Snapshot
9.3.1. U.K. Veterinary Oncology Market
9.3.2. Germany Veterinary Oncology Market
9.3.3. France Veterinary Oncology Market
9.3.4. Spain Veterinary Oncology Market
9.3.5. Italy Veterinary Oncology Market
9.3.6. Rest of Europe Veterinary Oncology Market
9.4. Asia-Pacific Veterinary Oncology Market Snapshot
9.4.1. China Veterinary Oncology Market
9.4.2. India Veterinary Oncology Market
9.4.3. Japan Veterinary Oncology Market
9.4.4. Australia Veterinary Oncology Market
9.4.5. South Korea Veterinary Oncology Market
9.4.6. Rest of Asia Pacific Veterinary Oncology Market
9.5. Latin America Veterinary Oncology Market Snapshot
9.5.1. Brazil Veterinary Oncology Market
9.5.2. Mexico Veterinary Oncology Market
9.6. Rest of The World Veterinary Oncology Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. PetCure Oncology
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Therapy Summary
10.2.1.5. Recent Developments
10.2.2. Zoetis
10.2.3. Karyopharm Therapeutics, Inc.
10.2.4. Varian Medical Systems
10.2.5. Accuray Incorporated
10.2.6. Boehringer Ingelheim GmbH
10.2.7. Elanco
10.2.8. One Health
10.2.9. Regeneus Ltd.
10.2.10. Morphogenesis, Inc
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Veterinary Oncology Market, report scope
TABLE 2. Global Veterinary Oncology Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Veterinary Oncology Market estimates & forecasts by Therapy 2018-2028 (USD Million)
TABLE 4. Global Veterinary Oncology Market estimates & forecasts by Animal Type 2018-2028 (USD Million)
TABLE 5. Global Veterinary Oncology Market estimates & forecasts by Cancer Type 2018-2028 (USD Million)
TABLE 6. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 7. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. U.S. Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. U.S. Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 18. U.S. Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. Canada Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 20. Canada Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 21. Canada Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. UK Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 23. UK Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 24. UK Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. Germany Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 26. Germany Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 27. Germany Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. RoE Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 29. RoE Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 30. RoE Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. China Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 32. China Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 33. China Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. India Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 35. India Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 36. India Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. Japan Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 38. Japan Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 39. Japan Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. RoAPAC Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 41. RoAPAC Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 42. RoAPAC Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. Brazil Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 44. Brazil Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 45. Brazil Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Mexico Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 47. Mexico Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 48. Mexico Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. RoLA Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 50. RoLA Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 51. RoLA Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. Row Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 53. Row Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 54. Row Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Veterinary Oncology Market
TABLE 56. List of primary sources, used in the study of global Veterinary Oncology Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
TABLE 1. Global Veterinary Oncology Market, report scope
TABLE 2. Global Veterinary Oncology Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Veterinary Oncology Market estimates & forecasts by Therapy 2018-2028 (USD Million)
TABLE 4. Global Veterinary Oncology Market estimates & forecasts by Animal Type 2018-2028 (USD Million)
TABLE 5. Global Veterinary Oncology Market estimates & forecasts by Cancer Type 2018-2028 (USD Million)
TABLE 6. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 7. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. U.S. Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. U.S. Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 18. U.S. Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. Canada Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 20. Canada Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 21. Canada Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. UK Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 23. UK Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 24. UK Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. Germany Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 26. Germany Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 27. Germany Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. RoE Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 29. RoE Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 30. RoE Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. China Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 32. China Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 33. China Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. India Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 35. India Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 36. India Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. Japan Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 38. Japan Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 39. Japan Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. RoAPAC Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 41. RoAPAC Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 42. RoAPAC Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. Brazil Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 44. Brazil Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 45. Brazil Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Mexico Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 47. Mexico Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 48. Mexico Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. RoLA Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 50. RoLA Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 51. RoLA Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. Row Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 53. Row Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 54. Row Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Veterinary Oncology Market
TABLE 56. List of primary sources, used in the study of global Veterinary Oncology Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Veterinary Oncology Market, research methodology
FIG 2. Global Veterinary Oncology Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Veterinary Oncology Market, key trends 2021
FIG 5. Global Veterinary Oncology Market, growth prospects 2022-2028
FIG 6. Global Veterinary Oncology Market, porters 5 force model
FIG 7. Global Veterinary Oncology Market, pest analysis
FIG 8. Global Veterinary Oncology Market, value chain analysis
FIG 9. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 10. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 11. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 12. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 13. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 14. Global Veterinary Oncology Market, regional snapshot 2018 & 2028
FIG 15. North America Veterinary Oncology Market 2018 & 2028 (USD Million)
FIG 16. Europe Veterinary Oncology Market 2018 & 2028 (USD Million)
FIG 17. Asia pacific Veterinary Oncology Market 2018 & 2028 (USD Million)
FIG 18. Latin America Veterinary Oncology Market 2018 & 2028 (USD Million)
FIG 19. Global Veterinary Oncology Market, company Market share analysis (2021)
FIG 1. Global Veterinary Oncology Market, research methodology
FIG 2. Global Veterinary Oncology Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Veterinary Oncology Market, key trends 2021
FIG 5. Global Veterinary Oncology Market, growth prospects 2022-2028
FIG 6. Global Veterinary Oncology Market, porters 5 force model
FIG 7. Global Veterinary Oncology Market, pest analysis
FIG 8. Global Veterinary Oncology Market, value chain analysis
FIG 9. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 10. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 11. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 12. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 13. Global Veterinary Oncology Market by segment, 2018 & 2028 (USD Million)
FIG 14. Global Veterinary Oncology Market, regional snapshot 2018 & 2028
FIG 15. North America Veterinary Oncology Market 2018 & 2028 (USD Million)
FIG 16. Europe Veterinary Oncology Market 2018 & 2028 (USD Million)
FIG 17. Asia pacific Veterinary Oncology Market 2018 & 2028 (USD Million)
FIG 18. Latin America Veterinary Oncology Market 2018 & 2028 (USD Million)
FIG 19. Global Veterinary Oncology Market, company Market share analysis (2021)
